Paxlovid doesnâ€™t reduce risk of long COVID, UCSF study finds
-----
The COVID-19 treatment Paxlovid does not reduce the risk of long COVID for vaccinated people who've tested positive for the virus for the first time, according to a new study by UCSF researchers.The study, published Thursday in the Journal of Medical Virology, also found that a higher share than previously reported experienced rebound symptoms and tested positive for COVID after taking the antiviral medication.
The new study suggests that other COVID-19 prevention strategies, like
